Hamburg, Thursday, Oct. 11, 2012 -

Home Members Join Closed User Group auspices ESC Fellowship DGK-Congresses Annual Meeting Fall Meeting Calendar of Events Guidelines Awards and Scholarships young talent About Us Board Commissions project groups work groups work groups Sections Contact The DGK Academy "Cardiology" and continuing education curricula publications DGK Cardiology Portal Journals / Print Certification Press patients Links Imprint
Navigation: Home / Press Releases / 2012 - Fall Meeting of the DGK and Annual osteoporoza Meeting of the Working Group Rhythmology osteoporoza / Latest press releases by DGK / Thursday, October 11, 2012 / Fewer and fewer cardiac deaths in Germany - wide regional variations - heart attack is men's, heart failure, women's business
Hamburg, Thursday, Oct. 11, 2012 - "The mortality from the most common cardiovascular disease osteoporoza is declining in Germany, moreover, the proportion of fatal heart disease in all diseases constantly," reports Prof. Dr. Georg Ertl (Director the Medical Clinic of Würzburg), President of the German Society of Cardiology at the Fall Meeting of the DGK and the annual meeting of the Working Group Rhythmology in Hamburg. "Between the end of the 1990s and 2010, the mortality in acute myocardial infarction and ischemic heart diseases (diseases worse as a result of blood flow) is in Germany fell by around 20 percent."
In detail: osteoporoza In chronic ischemic heart disease died in 1998 in Germany 95,000 people (11.1 percent of all deaths), as there were 72,700 (8.5 percent). On acute myocardial infarction died in 1998 76,000 people (8.9 percent), today there are 55,500 (6.5 per cent).
"The mortality rate for cardiovascular diseases varies greatly depending on the region," sums up the DGK-President: It is, for example - in terms of all deaths - in Baden-Württemberg in chronic ischemic heart disease 7.2 percent and in acute myocardial infarction osteoporoza 6, 5 percent, in Saxony-Anhalt, however 11.3 percent and 8.5 percent. (2010)
The general decline in mortality from cardiovascular disease is inextricably linked to the impressive osteoporoza developments in cardiology and heart surgery, which will be presented at the Fall Conference of the DGK. "Dealing with such innovative treatments requires a reasonable and efficient use, in which it comes to issues of quality assurance, cost effectiveness osteoporoza and evidence-basing," says Prof. Ertl. Safety and benefit, and the acute and long-term success must be supported. This is ensured by the consistent inclusion of patients osteoporoza in clinical trials and registries. osteoporoza The DGK sees one of its roles is to accompany such therapeutic innovations scientifically. "
Contact: Press Office of DGK Graf Allee 100 40237 Dusseldorf Tel .: + 49 211 600692-43 Fax: + 49 211 600692-10 presse@dgk.org Prof. Dr. Eckart Fleck (Spokesperson, Berlin) Kerstin Stein (press office, Dusseldorf)
The German Society of Cardiology - Heart and Circulatory Research eV (DGK), headquartered in Dusseldorf is a scientific medical society with more than 8000 members. Their aim is to promote science in the field of cardiovascular disease, hosting meetings and training and continuing education of its members. Founded in 1927 in Bad Nauheim, the DGK is the oldest and largest cardiology society in Europe. osteoporoza More information at www.dgk.org.